BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30442512)

  • 1. Patients' and prescribers' perception of contact lenses as a potential ocular drug delivery system.
    Ghazal H; Ahmadouk J; Dhanji S; El-Bushra A; Kayyali R; ElShaer A
    Cont Lens Anterior Eye; 2019 Apr; 42(2):190-195. PubMed ID: 30442512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular drug delivery systems: glaucoma patient perceptions from a German university hospital eye clinic.
    Weber C; Quintin P; Holz FG; Fea A; Mercieca K
    Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):545-556. PubMed ID: 37776338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inner layer-embedded contact lenses for pH-triggered controlled ocular drug delivery.
    Zhu Q; Liu C; Sun Z; Zhang X; Liang N; Mao S
    Eur J Pharm Biopharm; 2018 Jul; 128():220-229. PubMed ID: 29730260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey to Determine Perceptions and Practices in Contact Lens Use and Identify Key Features of Safe Use Education.
    Şengör T; Alkibay S; Ermeç Sertoğlu A; Aydın Kurna S
    Turk J Ophthalmol; 2018 Dec; 48(6):288-294. PubMed ID: 30605934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Acceptance of Sustained Glaucoma Treatment Strategies.
    Varadaraj V; Kahook MY; Ramulu PY; Pitha IF
    J Glaucoma; 2018 Apr; 27(4):328-335. PubMed ID: 29462013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review on contact lens for ophthalmic drug delivery.
    Xu J; Xue Y; Hu G; Lin T; Gou J; Yin T; He H; Zhang Y; Tang X
    J Control Release; 2018 Jul; 281():97-118. PubMed ID: 29782944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient attitudes toward novel glaucoma drug delivery approaches.
    Wang BB; Lin MM; Nguyen T; Turalba AV
    Digit J Ophthalmol; 2018; 24(2):16-23. PubMed ID: 30800009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
    Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
    Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics.
    Chaudhari P; Ghate VM; Lewis SA
    Eur J Pharm Biopharm; 2021 Apr; 161():80-99. PubMed ID: 33607239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo Studies Evaluating the Use of Contact Lenses for Drug Delivery.
    Hui A; Willcox M
    Optom Vis Sci; 2016 Apr; 93(4):367-76. PubMed ID: 26784709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact lenses for drug delivery.
    Ciolino JB; Dohlman CH; Kohane DS
    Semin Ophthalmol; 2009; 24(3):156-60. PubMed ID: 19437351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into Australian optometrists' knowledge and attitude towards prescribing blue light-blocking ophthalmic devices.
    Singh S; Anderson AJ; Downie LE
    Ophthalmic Physiol Opt; 2019 May; 39(3):194-204. PubMed ID: 30957274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic contact lenses for the treatment of corneal and ocular surface diseases: Advances in extended and targeted drug delivery.
    Abdi B; Mofidfar M; Hassanpour F; Kirbas Cilingir E; Kalajahi SK; Milani PH; Ghanbarzadeh M; Fadel D; Barnett M; Ta CN; Leblanc RM; Chauhan A; Abbasi F
    Int J Pharm; 2023 May; 638():122740. PubMed ID: 36804524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epalrestat-loaded silicone hydrogels as contact lenses to address diabetic-eye complications.
    Alvarez-Rivera F; Concheiro A; Alvarez-Lorenzo C
    Eur J Pharm Biopharm; 2018 Jan; 122():126-136. PubMed ID: 29079419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact lenses as drug-delivery systems: a promising therapeutic tool.
    Holgado MA; Anguiano-Domínguez A; Martín-Banderas L
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):24-33. PubMed ID: 31420118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there scope for expanding the optometrist's scope of practice in Singapore? - A survey of optometrists, opticians in Singapore.
    George PP; Yun OCS; Siow K; Saxena N; Heng BH; Car J; Lockwood C
    Cont Lens Anterior Eye; 2019 Jun; 42(3):258-264. PubMed ID: 30819628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optometrist prescribing of therapeutic agents: findings of the AESOP survey.
    Mason A; Mason J
    Health Policy; 2002 May; 60(2):185-97. PubMed ID: 11897376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches in topical ocular drug delivery and developments in the use of contact lenses as drug-delivery devices.
    Mehta P; Haj-Ahmad R; Al-Kinani A; Arshad MS; Chang MW; Alany RG; Ahmad Z
    Ther Deliv; 2017 Jul; 8(7):521-541. PubMed ID: 28633591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.